Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort ot the PREDICTIVE study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F08%3A00015957" target="_blank" >RIV/00843989:_____/08:00015957 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort ot the PREDICTIVE study
Original language description
The PREDICTIVE study is a multinational observational study designed to follow up patients with diabetes who started insulin detemir in routine care. We report 12-week follow-up data for patients with type 1 or type 2 diabetes who, as part of basal-bolustherapy, switched from once- or twice-daily neutral protamine Hagedorn insulin (NPH) to once daily. End-points evaluated from patients records and diaries - were incidence of serious adverse drug reaction, glycaemic parameters, hypoglycaemia and weightchange.
Czech name
Převod z NPH inzulínu na inzulín detemir podávaný v 1 denní dávce u nemocných s diabetem léčených v režimu bazal-bolus: data z evropské kohorty studie PREDICTIVE
Czech description
Studie PREDICTIVE byla mezinárodní observační studie designována ke sledování nemocných s diabetem, kteří zahájili léčbu inzulínem detemir v běžné klinické praxi.

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—

Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)